UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients

American journal of transplantation, 2014-09, Vol.14 (9), p.2106-2119

2014

Volltextzugriff (PDF)

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

British journal of dermatology (1951), 2016-11, Vol.175 (5), p.1073-1075

2016

Volltextzugriff (PDF)

Sotrastaurin in Calcineurin Inhibitor–Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients

American journal of transplantation, 2013-07, Vol.13 (7), p.1757-1768

2013

Volltextzugriff (PDF)

Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results

American journal of transplantation, 2013-07, Vol.13 (7), p.1746-1756

2013

Volltextzugriff (PDF)

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1‐Year, Randomized Controlled Trial in Europe and Australasia

American journal of transplantation, 2006-12, Vol.6 (12), p.2912-2921

2006

Volltextzugriff (PDF)

Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection

Transplantation, 2000-06, Vol.69 (12), p.2658

2000

Volltextzugriff (PDF)

Interleukin‐18 Affects Local Cytokine Expression But Does Not Impact on the Development of Kidney Allograft Rejection

American journal of transplantation, 2006-11, Vol.6 (11), p.2612-2621

2006

Volltextzugriff (PDF)

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I

Immunology and cell biology, 2001-06, Vol.79 (3), p.213-221

2001

Volltextzugriff (PDF)

Macrophage-derived interleukin-18 in experimental renal allograft rejection

Nephrology, dialysis, transplantation, 2005-04, Vol.20 (4), p.699-706

2005

Volltextzugriff (PDF)

Anergic Self-Reactive B Cells Present Self Antigen and Respond Normally to CD40-Dependent T-Cell Signals but are Defective in Antigen-Receptor- Mediated Functions

Proceedings of the National Academy of Sciences - PNAS, 1994-05, Vol.91 (10), p.4392-4396

1994

Volltextzugriff (PDF)

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

Transplantation, 2009-01, Vol.87 (2), p.233

2009

Volltextzugriff (PDF)

Vascular endothelial growth factor expression in human chronic renal allograft rejection

Transplantation, 1999-03, Vol.67 (6), p.929

1999

Volltextzugriff (PDF)

Drug points: Premature osteonecrosis and sirolimus treatment in renal transplantation

BMJ (Online), 2001-09, Vol.323 (7314), p.665

2001

Volltextzugriff (PDF)

Graft Function, Cardiovascular Risk Factors, and Sex Hormones in Renal Transplant Recipients on an Immunosuppressive Regimen of Everolimus, Reduced Dose of Cyclosporine, and Basiliximab

Transplantation proceedings, 2005-04, Vol.37 (3), p.1601-1604

2005

Volltextzugriff (PDF)

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

Transplantation, 2001-09, Vol.72 (5), p.777

2001

Volltextzugriff (PDF)

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

European journal of clinical pharmacology, 2000-08, Vol.56 (5), p.395-398

2000

Volltextzugriff (PDF)

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

American journal of transplantation, 2010-12, Vol.10 (12), p.2632-2643

2010

Volltextzugriff (PDF)

Sirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant Patients

Transplantation proceedings, 2005-03, Vol.37 (2), p.693-696

2005

Volltextzugriff (PDF)

Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction

Nephrology, dialysis, transplantation, 2013-02, Vol.28 (2), p.327-336

2013

Volltextzugriff (PDF)

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

Transplantation proceedings, 2003-05, Vol.35 (3), p.S115-S117

2003

Volltextzugriff (PDF)

Increased Risk of Hemorrhagic Complications in Renal Allograft Recipients Receiving Systemic Heparin Early Posttransplantation

Transplantation proceedings, 2005-03, Vol.37 (2), p.1026-1028

2005

Volltextzugriff (PDF)

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

American journal of transplantation, 2004-04, Vol.4 (4), p.626-635

2004

Volltextzugriff (PDF)

Frequency of cytochrome P 450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

European journal of clinical pharmacology, 2000-08, Vol.56 (5), p.395-398

2000

Volltextzugriff (PDF)

Cyclosporine withdrawal improves long-term graft survival in renal transplantation

Transplantation, 2009-06, Vol.87 (12), p.1877

2009

Volltextzugriff (PDF)

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement

Medical journal of Australia, 2005-08, Vol.183 (3), p.138-141

Mathew, Timothy H

2005

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Aktive Filter

Publikationsformmagazinearticle

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Englisch
(160)
Japanisch
(20)
Deutsch
(2)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(90)
Humans
(65)
Male
(47)
Female
(42)
Transplantation
(39)
Adult
(38)
Biological And Medical Sciences
(37)
Medical Sciences
(36)
Middle Aged
(35)
Surgery
(30)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(25)
Technology
(24)
Computer Science
(22)
Immunology
(21)
Kidney Transplantation
(20)
Aged
(18)
Computer Science, Artificial Intelligence
(17)
Surgery Of The Urinary System
(17)
Kidney Transplantation - Immunology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

Sotrastaurin in Calcineurin Inhibitor–Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients

Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1‐Year, Randomized Controlled Trial in Europe and Australasia

Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection

Interleukin‐18 Affects Local Cytokine Expression But Does Not Impact on the Development of Kidney Allograft Rejection

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I

Macrophage-derived interleukin-18 in experimental renal allograft rejection

Anergic Self-Reactive B Cells Present Self Antigen and Respond Normally to CD40-Dependent T-Cell Signals but are Defective in Antigen-Receptor- Mediated Functions

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

Vascular endothelial growth factor expression in human chronic renal allograft rejection

Drug points: Premature osteonecrosis and sirolimus treatment in renal transplantation

Graft Function, Cardiovascular Risk Factors, and Sex Hormones in Renal Transplant Recipients on an Immunosuppressive Regimen of Everolimus, Reduced Dose of Cyclosporine, and Basiliximab

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

Sirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant Patients

Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

Increased Risk of Hemorrhagic Complications in Renal Allograft Recipients Receiving Systemic Heparin Early Posttransplantation

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

Frequency of cytochrome P 450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

Cyclosporine withdrawal improves long-term graft survival in renal transplantation

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement

Aktive Filter

Suchergebnisse filtern